Nörobilim Ve Psikiyatri Hemşireliğinde Kullanımı: Hayal Ya Da Gerçek?

Year 2022, Volume: 12 Issue: 1, 202 - 213, 18.03.2022

Rahime Aslan , Hülya Arslantaş

https://doi.org/10.31832/smj.790693

Abstract

Nöronların keşfi ile başlayan ve gelişerek günümüzün popüler yaklaşımlarından biri olan nörobilim, biyolojik ve psikolojik bilimler arasında tamamlayıcı ilişkinin olduğu bir disiplindir. Beyin ile ilgili anatomik, fizyolojik bilgilerin artması ve görüntüleme bulguları ile birlikte beynin incelenmesinin mümkün olması nöral bağlantıların ve psikopatolojinin anlaşılmasını sağlamıştır. Böylece psikososyal ve nörobiyolojik yaklaşımı bütünleştirerek psikiyatrinin pozitif bilim olma yolunda ilerlemesinin önü açılmıştır. Psikiyatri alanındaki bu gelişmelere paralel olarak psikiyatri hemşireliği içinde biyolojik yaklaşımlar teorikte olduğu gibi uygulamada da önem kazanmıştır. Nörobilimin psikiyatri hemşireliği ile ilişkisini anlamamız; nöroplastisitenin geliştirilmesiyle, psikofarmakolojik tedavilerin, psikoterapilerin ve psikoterapötik müdahalelerin etkilerinin nörogörüntülemelerle izlenmesiyle bakım anlayışımıza katkı sağlayacaktır. Bu amaçla derlemede nörobilimin gelişmesine, psikiyatride paradigma değişimine, psikiyatrik hastalıklarda ve tedavilerde nörobilime, nörobilim hemşireliği standartlarına, psikiyatri hemşireliğinde nörobilimin kullanımına ve ilgili araştırmalara yer verilmiştir.

Keywords

Nörobilim, Psikiyatri hemşireliği, Nörobiyoloji

Supporting Institution

YOKTUR

Project Number

YOKTUR

Thanks

Manisa Celal Bayar Üniversitesi Sağlık Bilimleri Fakültesi Hemşirelik Bölümü Ruh Sağlığı ve Hastalıkları Hemşireliği Anabilim DalıÖğretim Üyesi Doç. Dr. Sevgi NEHİR’e makale ile ilgili geribildirimi için teşekkür ederiz.

References

• 1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 5 st ed. Arlington, VA: American Psychiatric Association; 2013.
• 2. Uzbay T. Nöropsikofarmakoloji: Rasyonel ilaç kullanımı. 1.Baskı. İstanbul: Medikal Yayıncılık; 2007.
• 3. Fenton W, James R, Insel T. Psychiatry residency training, the physician-scientist, and the future of psychiatry. Academic Psychiatry 2004;28(4):263-266.
• 4. Kandel ER, Squire LR. Neuroscience: Breaking down scientific barriers to the study of brain and mind. Science 2000;290(5494):1113-1120.
• 5. Snell S. Klinik Nöroanatomi. Yıldırım M, editör. 1. Baskı. İstanbul: Sökmen Matbaacılık;2000.
• 6. McIntosh WH. Neuroscience and psychiatric nursing – it is worth thinking about. This article first appeared in the Summer 2012/13 edition of news magazine, a quarterly publication by the Australian College of Mental Health Nurses.
• 7. Cajal SR. Degeneration and regeneration of the nervous system. Clarendon Press;1928. p.236-245.
• 8. Sherrington C. The integrative action of the nervous system. CUP Archive;1952.
• 9. Burke RE. Sir Charles Sherrington's the integrative action of the nervous system: a centenary appreciation. Brain 2007;130(4):887-894.
• 10. Hebb DO. Organization of behavior. New York: Wiley. J. Clin. Psychol 1949;6(3):335-307.
• 11. Olds J, Milner P. Positive reinforcement produced by electrical stimulation of septal area and other regions of rat brain. Journal of comparative and physiological psychology 1954;47(6):419.-427.
• 12. Gaddum JH. Serotonin‐LSD interactions. Annals of the New York Academy of Sciences 1957;66(3): 643-648.
• 13. Schildkraut JJ. The catecholamine hypothesis of affective disorders: a review of supporting evidence. American journal of Psychiatry 1965;122(5):509-522.
• 14. Klavdieva MM. The history of neuropeptides II. Frontiers in neuroendocrinology 1996;17(1):126-153.
• 15. De Herder WW. Heroes in endocrinology: nobel prizes. Endocrine connections 2014;3(3):R94-R104.
• 16. Kim SG, Ogawa S. Insights into new techniques for high resolution functional MRI. Current opinion in neurobiology 2002;12(5):607-615.
• 17. Wicker B, Keysers C, Plailly J, Royet JP, Gallese V, Rizzolatti G. Both of us disgusted in My insula: the common neural basis of seeing and feeling disgust. Neuron 2003;40(3):655-664.
• 18. Insel TR, Quirion R. Psychiatry as a clinical neuroscience discipline. Jama 2005;294(17):2221-2224.
• 19. Insel T, Cuthbert B, Garvey M, Heinssen R, Pine DS, Quinn K, Wang PW. Research Domain Criteria (RDoC): Developing a valid diagnostic framework for research on mental disorders. American Journal of Psychiatry 2010;167(7):748-751.
• 20. Duman RS. Depression: a case of neuronal life and death?. Biological psychiatry 2004;56(3):140-145.
• 21. Rumpel S, LeDoux J, Zador A, Malinow R. Postsynaptic receptor trafficking underlying a form of associative learning. Science 2005;308(5718):83-88.
• 22. Bradshaw RA, Cook A, McDonald MJ. Observed & experiential integration (OEI): Discovery and development of a new set of trauma therapy techniques. Journal of Psychotherapy Integration 2011;21(2):104.
• 23. Rolls ET, Deco G. The noisy brain: stochastic dynamics as a principle of brain function. 1 st ed. New York: Oxford university pres;2010.
• 24. Koster EH, De Lissnyder E, Derakshan N, De Raedt R. Understanding depressive rumination from a cognitive science perspective: The impaired disengagement hypothesis. Clinical psychology review 2011;31(1):138-145.
• 25. Ishimaru MJ, Toru M. The glutamate hypothesisof schizophrenia: therapeutic implications. CNS Drugs 1997;7:47-62.
• 26. Coyle JT, Tsai G, Goff D. Converging evidence of NMDA receptor hypofunction in the pathophysiology of schizophrenia. Annals of the New York Academy of Sciences 2003;1003:318–327.
• 27. Howes O, McCutcheon R, Stone J. Glutamate and dopamine in schizophrenia: an update for the 21st century. J Psychopharmacol 2015;29:97-115.
• 28. Gargiula PA, De Gargiulo AIL. Glutamate and modeling of schizophrenia symptoms: review of our findings: 1990–2014. Pharmacological Reports 2014;66(3):343-352.
• 29. Fatemi SH. Clayton PJ. The Medical Basis of Psychiatry. 3 st ed. Totowa, NJ: Humana Press; 2008. p.85-108.
• 30. Ceylan ME, Taşçı D. Şizofrenide NMDA ve GABA sistemi. Şizofreni Dizisi 1999;2:68-75.
• 31. Belsham B. Glutamate and its role in psychiatric illness. Hum Psychopharmacol 2001;16:139-146.
• 32. Coyle JT. Glutamate and schizophrenia: beyond the dopamine hypothesis. Cell Mol Neurobiol 2006;26:365-384.
• 33. Kotan Z, Sarandol A, Eker SS, Akkaya C. Depresyon, nöroplastisite ve nörotrofik faktörler. Psikiyatride Guncel Yaklasimlar 2009;1:22-35.
• 34. Eker MC, Eker OD. Depresyon Patofizyolojisinde Hippokampusun Rolü/The Role of Hippocampus in the Pathophysiology of Depression. Psikiyatride Guncel Yaklasimlar 2009;1:11-21.
• 35. Hammond JC, Shan D, Meador-Woodruff JH, McCullumsmith RE. Evidence of Glutamatergic Dysfunction in the Pathophysiology of Schizophrenia. In: Popoli M, Diamond D, Sanacora G. (eds) Synaptic Stress and Pathogenesis of Neuropsychiatric Disorders. New York: Springer;2014.p.265-294. https://doi.org/10.1007/978-1-4939-1056-4_15
• 36. Meador-woodruff JH, Kleinman JE. Neurochemistry of schizophrenia: Glutamatergic abnormalities. In: Davis KL, Charney D, Coyle JT, Nemeroff C. eds. Neuropsychopharmacology: The Fifth Generation of Progress. New York: Lippincott Williams and Wilkins; 2002.p. 717-728.
• 37. Gotlieb IH, Hamilton JP. Neuroimaging and depression: Current status and unresolved issues. Current Directions of Psychological Science. 2008; 17:159–163.
• 38. Ochsner KN, Gross JJ. Cognitive emotion regulation: Insights from social cognitive and affective neuroscience. Currents Directions in Psychological Science 2008;17(1):153-158.
• 39. Eugene F, Joormann J, Cooney R, Atlas L, Gotlib IH. Neural correlates of inhibitory deficits in depression. Psychiatry Research 2011;181(1):30-35.
• 40. Johnstone T, van Reekum C, Urry H, Kalin N, Davidson R. Failure to regulate: Counterproductive recruitment of top-down prefrontal-subcortical circuitry in major depression. Journal of Neuroscience 2007; 27:8877–8884.
• 41. Shackman AJ, Fox AS, Oler JA, Shelton SE, Davidson RJ, Kalin NH. Neural mechanisms underlying heterogeneity in the presentation of anxious temperament. Proceedings of the National Academy of Sciences 2013;110:6145–6150.
• 42. Latalova K, Prasko J, Diveky T, Velartova H. Cognitive impairment in bipolar disorder. Biomedical Papers of the Medical Faculty of Palacky University in Olomouc 2011;155(1):19-26.
• 43. Bruno SD, Barker GJ, Cercignani M, Symms M, Ron MA. A study of bipolar disorder using magnetization transfer imaging and voxel-based morphometry. Brain 2004;127(11):2433-2440.
• 44. Phillips ML, Ladouceur CD, Drevets WC. A neural model of voluntary and automatic emotion regulation: implications for understanding the pathophysiology and neurodevelopment of bipolar disorder. Mol Psychiatry 2008;13:833-857.
• 45. Uzbay T. Anksiyete ve depresyonun nörobiyolojisi. Klinik Psikiyatri Ek 2004;4:3-11.
• 46. Beatson J, Taryan S. Predisposition to depression: the role of attachment. Predisposition to depression: the role of attachment. Australian & New Zealand Journal of Psychiatry 2003;37(2):219-225.
• 47. Charney DS. Psychobiological mechanisms of resilience and vulnerability: implications for successful adaptation to extreme stress. American journal of Psychiatry 2004;161(2):195-216.
• 48. Bergmann U. Neurobiological foundations for EMDR practice. New York: Springer;2012.
• 49. Shapiro F. Eye movement desensitization and reprocessing (EMDR): Basic principles, protocols and procedures. 2 st ed. New York: Guilford Press;2001.
• 50. Shewfelt M. The relationship is the therapy: applying interpersonal neurobiology in psychotherapy. The Neuropsychotherapıst 2018;6 (12):62-71.
• 51. Erbay LG, Ünal S. Terapi beyinde ne yapar?. Türkiye Klinikleri Çocuk Psikiyatrisi-Özel Konular 2017;3(2):163-168.
• 52. Beck AT. Cognitive therapy and the emotional disorders. Penguin;1979.
• 53. Goldapple K, Segal Z, Garson C, Lau M, Bieling P, Kennedy S, Mayberg H. (2004). Modulation of cortical-limbic pathways in major depression: Treatment-specific effects of cognitive behavior therapy. Archives of general psychiatry 2004;61(1):34-41.
• 54. Kennedy SH, Konarski JZ, Segal ZV, Lau MA, Bieling PJ, McIntyre RS, Mayberg HS. Differences in brain glucose metabolism between responders to CBT and venlafaxine in a 16-week randomized controlled trial. American Journal of Psychiatry 2007;164(5):778-788.
• 55. Baxter LR Jr, Schwartz JM, Bergman KS, Szuba MP, Guze BH, Mazziotta JC, Phelps ME. Caudate glucose metabolic rate changes with both drug and behavior therapy for obsessive compulsive disorder. Archives of general psychiatry 1992;49(9):681-9.
• 56. Furmark T, Tillfors M, Marteinsdottir I, Fischer H, Pissiota A, Långström B, Fredrikson M. Common changes in cerebral blood flow in patients with social phobia treated with citalopram or cognitive behavioral therapy. Archives of general psychiatry 2002;59(5):425-33.
• 57. Paquette V, Lévesque J, Mensour B, Leroux JM, Beaudoin G, Bourgouin P, Beauregard M. “Change the mind and you change the brain”: effects of cognitive-behavioral therapy on the neural correlates of spider phobia. Neuroimage 2003;18(2):401-9.
• 58. Gabbart GO, Bennett TJ. Psychodynamic psychotherapy of depression. Gabbard’streatments of psychiatric disorders. Alptekin K, Öztürk Ö, çeviri editörü. 1. Baskı. Ankara: Veri Medikal Yayıncılık;2001.p.433-38.
• 59. American Nurses Association (ANA). Nursing’s social policy statement: The essence of the profession. Silver Spring, MD: Nursesbooks.org;2010a.
• 60. American Nurses Association (ANA). Nursing: Scope and standards of practice. 2 st ed. Silver Spring, MD: Nursesbooks.org;2010b.
• 61. Thompson HJ, Kirkness CJ, Mitchell PH, Webb DJ. Fever management practices of neuroscience nurses: national and regional perspectives J Neurosci Nurs. 2007;39(3):151-162. doi:10.1097/01376517-200706000-00005
• 62. https://everynurse.org/careers/neuroscience-nurse/ Accessed: 26.08.2020.
• 63. Stewart-Amidei C, Villanueva N, Schwartz RR, Delemos C, West T, Tocco S, Haymore J. Amerikan Nörobilim Hemşireleri Derneği, sinirbilim ileri uygulama hemşireleri için uygulama alanı ve standartları. Sinirbilim Hemşireliği Dergisi 2010;42(3):E1-E8.
• 64. https://radiologykey.com/scope-of-neuroscience-nursing-practice/ Accessed: 26.06.2020.
• 65. Bader MK, Littlejohns L. AANN Core Curriculum for Neuroscience Nursing. 5 st ed. Chicago: Wolters Kluwer Health;2010.
• 66. Varcarolis EM, Halter MJ. Essentials of Psychiatric Mental Health Nursing: A Communication Approach to Evidence-Based Care. 3 st ed. China: Saunders Elseiver;2009.
• 67. Chiverton P, LaForest ML, Bowen J. Neuropsychiatric Nursing: A Useful Adjunct to Comprehensive Neuroscience Nursing Care. Journal of Neuroscience Nursing 1994;26(2):67-72.
• 68. Nasrallah HA. Advancing clinical neuroscience literacy among psychiatric practitioners. Current Psychiatry 2017;16(9):17-18.
• 69. Hughes AE, Crowell SE, Uyeji L, Coan JA. A developmental neuroscience of borderline pathology: Emotion dysregulation and social baseline theory. Journal of abnormal child psychology 2012;40(1):21-33.
• 70. Northoff G, Bermpohl F, Schoeneich F, Boeker H. How does our brain constitute defence mechanisms? First-person neuroscience and psychoanalysis. Psychotherapy and Psychosomatics 2007;76:141-153.
• 71. Yaniv D. Dynamics of creativity and empathy in role reversal: Contributions from neuroscience. Review of General Psychology 2012;16(1):70-77.
• 72. Cozolino L. The neuroscience of human relationships: Attachment and the developing brain. 1 st ed. New York: W.W. Norton;2006.
• 73. Casey B, Long A. Re concilling voices. Journal of Psychiatric and Mental Health Nursing 2002;9 (5):603-610.
• 74. Ross DA, Travis MJ, Arbuckle MR. The future of psychiatry as clinical neuroscience: why not now?. JAMA psychiatry 2015;72(5): 413-414.
• 75. Weiss RP. The Wave of the Brain, Training & Development 2000; p.21-24.
• 76. Antai-Otong D. The neurobiology of anxiety disorders: Implications for psychiatric nursing practice. Issues in mental health nursing 2000;21(1):71-89.
• 77. Vancampfort D, Probst M, Hert MD, Soundy A, Stubbs B, Stroobants M, Herdt AD Neurobiological effects of physical exercise in schizophrenia: a systematic review. Disability and rehabilitation 2014;36(21):1749-54.